10
landing page
FasterCures and COVID-19
Ending the Crisis
The goal of FasterCures is to understand how industry and government are working
to end the COVID-19 crisis. To help us in this mission, we have created Four Pillars., FasterCures: COVID-19 Action Recommendations
Learn More About the Recommendations
+ Read More
panel
FasterCures Roundtable (Invite only)
As health systems worldwide recover and rebuild in the retention wake of COVID-19, the importanc
e of early preparation, multi-stakeholder collaboration, and constant innovation must not be forgotten.
+ Read More
panel
Private Lunch Hosted by FasterCures (Invite only)
Global health security—progress toward a world safe and secure from infectious-disease threats—i
s a growing priority in the US and globally.
+ Read More
panel
Private Breakfast Hosted by FasterCures (Invite only)
Averting an AMR Disaster: How Prepared Are We?
article
FasterCures Changemakers
What is the power of philanthropy to disrupt the biomedical innovation ecosystem?
panel
Private Breakfast Hosted by FasterCures on Biomedical Innovation (Invite only)
An intimate gathering of high-level executives and officials to discuss how to strengthen source
s of growth capital for emerging life sciences/tech businesses in the UK innovation sector.
+ Read More
article
FasterCures: 2019 In Review
Our 2019 Work at a Glance
FasterCures' focus in 2019 was to ensure our mission was well-understood
and aligned with our programmatic work.
+ Read More
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More
video
Advances in Science: Beyond “One Disease at a Time:” Therapeutic Platforms for Monogenic Disease
Guest speaker Philip John (P.J.) Brooks, PhD, acting director of the Division of Rare Diseases Res
earch Innovation at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) delivered a presentation about cell an
+ Read More
article
Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs
Submitted electronically